Citrobacter meningitis and brain abscess in infancy: Epidemiology, pathogenesis, and treatment

The Journal of Pediatrics

Volumn 113, Issue 3, 1988, Pages 430-434

  Kline, Mark W ^a  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE; CEPHALOSPORIN DERIVATIVE; COTRIMOXAZOLE; LATAMOXEF;

ANTIBIOTIC THERAPY; BACTERIAL MENINGITIS; BRAIN ABSCESS; CITROBACTER; HUMAN; INFANT; NONHUMAN; PRIORITY JOURNAL; REVIEW;

ANTIBIOTICS; BRAIN ABSCESS; CITROBACTER; DISEASE OUTBREAKS; ENTEROBACTERIACEAE INFECTIONS; HUMAN; INFANT; MENINGITIS;

EID: 0023718331     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-3476(88)80623-1     Document Type: Article

References (49)

1. Enterobacteriaceae
2. Bacterial sepsis and meningitis
3. Bacteria producing trimethylene glycol
4. A group of paracolon organisms having apparent pathogenicity
5. The so-called “paracolon” bacteria: a bacteriologic and clinical reappraisal
6. Clinical and bacteriologic observations on a recently recognized species of Enterobacteriaceae, Citrobacter diversus
7. Citrobacter diversus at Grace Hospital, Detroit, Michigan
8. Clinical significance of citrobacter isolates
9. Citrobacter infections in humans: experience at the Seattle Veterans Administration Medical Center and a review of the literature
10. Bacteremias due to Citrobacter diversus and Citrobacter freundii: incidence, risk factors, and clinical outcome
11. Nosocomial infection surveillance, 1984
12. Escherichia freundii meningitis: report of two cases
13. Proteus and coliform meningoencephalitis in neonates
14. Cerebral abscesses complicating neonatal Citrobacter freundii meningitis
15. Citrobacter infections of the central nervous system in early infancy
16. Citrobacter diversus brain abscess and meningitis in neonates
17. Neonatal Citrobacter meningitis
18. Neonatal meningitis caused by Citrobacter koseri
19. Citrobacter diversus meningitis: a case report
20. Citrobacter meningitis and cerebral abscess in early infancy: cure by moxalactam
21. Neonatal intracranial abscess: two cases caused by Citrobacter and a literature review
22. Citrobacter ventriculitis in a neonate responsive to trimethoprim-sulfamethoxazole
23. Conservative management of Citrobacter diversus meningitis with brain abscess
24. Citrobacter diversus and neonatal brain abscess
25. Citrobacter koseri meningitis in a special care baby unit
26. Epidemic nosocomial meningitis due to Citrobacter diversus in neonates
27. Gram-negative sepsis in neonates: a nursery outbreak due to hand carriage of Citrobacter diversus
28. Nosocomial meningitis due to Citrobacter diversus in neonates: new aspects of the epidemiology
29. Moxalactam therapy for neonatal meningitis due to gram-negative enteric bacilli: a prospective controlled evaluation
30. Infections of the central nervous system
31. Characterization of Citrobacter diversus strains causing neonatal meningitis
32. Molecular epidemiology of neonatal meningitis due to Citrobacter diversus: a study of isolates from hospitals in Maryland
33. Cytotoxin production by Citrobacter and Escherichia coli strains isolated from infants with CNS disease
34. Etude taxonomique de “Levinea,” nouveau genre de la famille des enterobacteries
35. Citrobacter koseri (syn. C. diversus): biotype, serogroup and drug resistance patterns of 517 strains
36. Pathogenesis of brain abscess formation in an infant rat model of Citrobacter diversus bacteremia and meningitis
37. Haemophilus influenzae meningitis in infant rats: role of bacteremia in pathogenesis of age-dependent inflammatory responses in cerebrospinal fluid
38. Biochemical and antibiotic susceptibility studies of hydrogen sulfide-negative Citrobacter
39. Aztreonam: the first monobactam
40. Review of in vitro activity of third-generation cephalosporins and other newer beta-lactam antibiotics against clinically important bacteria
41. Aztreonam: antibacterial activity, beta-lactamase stability, and interpretive standards and quality control guidelines for disk-diffusion susceptibility tests
42. Successful moxalactam therapy for gram-negative bacillary meningitis in neonates
43. Intracellular penetration and antimicrobial activity of antibiotics
44. Gentamicin antibacterial activity in the presence of human polymorphonuclear leukocytes
45. Chronic granulomatous disease mode of action of sulfamethoxazole-trimethoprim
46. Trimethoprim-sulfamethoxazole therapy for relapses of Salmonella meningitis
47. Treatment of meningitis and septicemia in infancy with sulfamethoxazole/trimethoprim
48. Relapsing E. coli K1 antigen meningitis in a newborn
49. Trimethoprim-sulfamethoxazole for bacterial meningitis